Clinical trial
First-In Man (FIM) Study MR-Linac
NCT03284619 is registered in ClinicalTrials.gov with Nucletron Operations BV as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- First-In Man (FIM) Study MR-Linac
- Lead sponsor
- Nucletron Operations BV
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2017
- Completion date
- September 8, 2017
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bone metastases